Invention Grant
- Patent Title: Heterocyclylamines as PI3K inhibitors
- Patent Title (中): 杂环胺作为PI3K抑制剂
-
Application No.: US13601349Application Date: 2012-08-31
-
Publication No.: US09199982B2Publication Date: 2015-12-01
- Inventor: Yun-Long Li , Andrew P. Combs , Eddy W. Yue , Brent Douty , Song Mei
- Applicant: Yun-Long Li , Andrew P. Combs , Eddy W. Yue , Brent Douty , Song Mei
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04
Abstract:
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Public/Granted literature
- US20130059835A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS Public/Granted day:2013-03-07
Information query
